Pain

Research published in the Journal of Dental Research has shown CBD’s potential as a safe and effective alternative to opioids for acute dental pain, marking a significant advancement in pain management and opioid alternative research. The study, conducted by scientists from...

In a groundbreaking study of epic proportions, researchers weighed the pain-alleviating potential of medical marijuana versus opioids, showing that cannabis is similarly effective as opioids and traditional pain meds for the treatment of non-cancer pain. “Our findings suggest that...

This article was originally published on Cannabis.net and appears here with permission. The number of conditions that cannabis has been studied to treat continues to grow each year. There are some health conditions where psychoactive THC (tetrahydrocannabinol) and calming...

Cannabis helps with cancer-related pain, a Canadian team of experts has concluded. Their study, published in BMJ Supportive & Palliative Care, confirmed that medicinal marijuana is a "safe and effective complementary treatment for pain relief in patients with cancer." ...

CBD oil without THC does not help advanced cancer patients with their pain, depression, anxiety and overall quality of life, a new study found. The study, however, looked at the effect of CBD alone, said lead author Prof Janet Hardy. "The cannabis plant is very complex...

Canopy Growth Corporation’s (TSX: WEED) (NASDAQ: CGC) announced positive results from a six-month, randomized clinical trial studying the effects of cannabidiol (CBD) on menstrual-related symptoms. This study was conducted in collaboration with Dr. Jessica G. Irons and Morgan L. Ferretti...

By The Fresh Toast's Brendan Bures, provided exclusively to Benzinga Cannabis. A new study found precise doses of THC administered via inhaler were effective in reducing pain in neuropathy patients. Marijuana’s therapeutic effects for chronic pain patients are well-known. Cannabis reduces...

Shares of Cara Therapeutics Inc (NASDAQ: CARA) fell nearly 30 percent early Friday morning after the company released concerning top-line results from a phase 2B trial of its oral CR845 therapy for the treatment of pain associated with osteoarthritis of the hip or knee. But not all analysts are...

Engineering graduate Ram Mukunda spent more than 25 years working in Wall Street. He served in companies communications firms Intelsat SA (NYSE: I) and Startec, before making an incursion into the mining industry through a company he co-founded. India Globalization Capital, Inc. (NYSE: IGC) was...

Eli Lilly and Co (NYSE: LLY) detailed in a presentation to the investment community its outlook for new product launches through 2023. Eli Lilly said that it has the potential to launch a total of 20 new products in the 10-year period beginning in 2014 and extending through 2023. In addition, the...